Prebiotics in infant milk formulas: new perspectives.
In recent years it has become accepted that healthy human intestinal microflora may play an important part in priming the infants' systemic and mucosal immunity. Dietary modulation of the gut microbiota is a topical area of nutritional sciences and the main focus of many current functional foods such as non-digestible oligosaccharides (NDOs). Fructo-oligosaccharides (FOS) and trans-beta-galacto-oligosaccharides (TOS) have been claimed to benefit the health of the colon by selectively stimulating the growth of bifidobacteria and lactobacilli (prebiotic effect). It could be of clinical interest to manipulate colonic flora because it is supposed that specific bacteria in the gut microbial microflora could promote potentially antiallergenic processes and play a key part in atopic disease prevention. Supporting this view is the finding that analysis of the composition of the intestinal bacterial populations showed different microbial patterns between healthy and allergic individuals. Assuming that non-digestible TOS and FOS can affect the intestinal ecosystem beneficially, the opportunity for gut flora manipulation arises in bottle-fed infants. New preterm and term infant milk formulas, supplemented with a mixture of TOS and FOS as prebiotic ingredients induced a significantly higher colonization of bifidobacteria and lactobacilli. In the future, selective manipulation of the intestinal microbiota might be an approach to novel prophylactic and therapeutic intervention strategies of atopy, by redirecting allergic Th-2 responses in favour of Th-1 responses.
Dipartimento di Biomedicina dell'Età Evolutiva, University of Bari, Italy. vito.miniello@libero.it
V L
VL
Miniello
G E
GE
Moro
L
L
Armenio
D001644:Bifidobacterium / Q000502:physiology; D006801:Humans; D006920:Hygiene; D006967:Hypersensitivity / Q000276:immunology / Q000382:microbiology; D007223:Infant; D041943:Infant Formula / Q000737:chemistry* / Q000494:pharmacology; D007422:Intestines / Q000382:microbiology*